Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy ; volume:9 ; number:2 ; year:2017 ; pages:135-136 ; extent:2
EMBO molecular medicine / European Molecular Biology Organization ; 9, Heft 2 (2017), 135-136 (gesamt 2)
- Urheber
- DOI
-
10.15252/emmm.201607219
- URN
-
urn:nbn:de:101:1-2022092906340350424218
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Ähnliche Objekte (12)
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Evaluation of tumor-infiltrating lymphocyte dysfunction in melanoma patients resistant to immune checkpoint blockade
Checkpoint
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma : Implications for Immune Checkpoint Blockade Therapy
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Evaluation of tumor-infiltrating lymphocyte dysfunction in melanoma patients resistant to immune checkpoint blockade
Checkpoint
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma : Implications for Immune Checkpoint Blockade Therapy
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Evaluation of tumor-infiltrating lymphocyte dysfunction in melanoma patients resistant to immune checkpoint blockade
Checkpoint
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment